ArticleJournal of psychiatric research2020

Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial.

Ian A Cook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.